Droloxifene citrate
CAS: 97752-20-0
Ref. 3D-FD76626
| 25mg | 143.00 € | ||
| 50mg | 189.00 € | ||
| 100mg | 288.00 € | ||
| 250mg | 478.00 € |
Product Information
- 3-[(E)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol citrate
- (E)-1-[4'-(2-Dimethylaminoethoxy)phenyl]-1-(3-hydroxyphenyl)-2-phenylbut-1-ene Citrate
- (E)-3-[1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol Citrate (1:1) (Salt)
- (E)-a-[p-[2-(dimethylamino)ethoxy]phenyl]-a'-ethyl-3-stilbenol Citrate
- 3-[(1E)-1-{4-[2-(Dimethylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl]phenol 2-hydroxypropane-1,2,3-tricarboxylate (1:1)
- 3-[(1E)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl]phenol 2-hydroxypropane-1,2,3-tricarboxylate (salt)
- 97752-20-0
- Phenol, 3-[(1E)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- Phenol, 3-[(1E)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt)
- Phenol, 3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]-, (E)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt)
- See more synonyms
Droloxifene is a selective estrogen receptor modulator that has been shown to be effective in the treatment of breast cancer. It is also used to treat postmenopausal osteoporosis and prevent osteoporotic fractures. Droloxifene binds to the estrogen receptors, preventing estradiol from binding. This prevents the proliferation of cancer cells, which are dependent on estrogens for growth. The drug has been shown to be well tolerated in human serum and not associated with any adverse effects.
Chemical properties
Technical inquiry about: 3D-FD76626 Droloxifene citrate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
